The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

Xi Wang^#¹, Ruiyuan Cao^#², Huanyu Zhang^#^{1

3}, Jia Liu¹, Mingyue Xu^{1

3}, Hengrui Hu^{1

3}, Yufeng Li^{1

3}, Lei Zhao², Wei Li², Xiulian Sun¹, Xinglou Yang¹, Zhengli Shi¹, Fei Deng^{1

4}, Zhihong Hu¹, Wu Zhong², Manli Wang¹

Affiliations

¹ 1State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071 China.
² 2National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850 China.
³ 3University of the Chinese Academy of Sciences, Beijing, 100049 China.
⁴ 4National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071 China.

^# Contributed equally.

Free PMC article

Xi Wang et al. Cell Discov. 2020.

Free PMC article

. 2020 May 2:6:28.

doi: 10.1038/s41421-020-0169-8. eCollection 2020.

¹ 1State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071 China.
² 2National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850 China.
³ 3University of the Chinese Academy of Sciences, Beijing, 100049 China.
⁴ 4National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071 China.

^# Contributed equally.

No abstract available

Keywords: Cell biology; Molecular biology.

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.